Beyond the Fog: Navigating the Complexities of Long-COVID-19

Author picture

Article written by Michelle Clark, ND
Clinical Education Manager, FxMed

Published 1 June 2024

People take supplements to improve or optimize their health. So what happens when you look at the label, and the ingredient list is filled with unrecognizable additives?

Long-COVID-19 (LC) is a complex and often debilitating condition that affects millions of people worldwide. With over 200 different symptoms impacting multiple organ systems, LC presents a significant challenge to patients and health practitioners alike.

Recent estimates suggest that approximately 10% of all COVID cases transition to LC, equating to over 65 million people globally, with an estimated 260,000 cases in New Zealand and 1.2 million in Australia. The impact on patients’ lives is profound, with 3–18% of people with LC reporting an inability to return to work at 12-month follow-up, leading to a substantial burden on families, healthcare systems and the workforce.

FxMed practitioner account holder content. Please log in to continue reading.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Related Posts

MCAS, Hypercoagulability & Biofilms

Dr Kelly McCann  23 September 2024 In this 50-minute episode,  Dr Kelly McCann explores the nuances of MCAS—what triggers it, how it manifests, and most

Revitalising Mitochondria

Dennis Schoen& Dr Taylor Krick, BSc, DC Protocols In Action, Season 1 – Part 3 of 3     22 February 2024 Whether patients are combating